192 related articles for article (PubMed ID: 8257154)
41. Macrophage activation by antiviral acyclic nucleoside phosphonates in dependence on priming immune stimuli.
Zídek Z; Franková D; Holý A
Int J Immunopharmacol; 2000 Dec; 22(12):1121-9. PubMed ID: 11137619
[TBL] [Abstract][Full Text] [Related]
42. Bisamidate Prodrugs of 2-Substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as Selective Inhibitors of Adenylate Cyclase Toxin from Bordetella pertussis.
Česnek M; Jansa P; Šmídková M; Mertlíková-Kaiserová H; Dračínský M; Brust TF; Pávek P; Trejtnar F; Watts VJ; Janeba Z
ChemMedChem; 2015 Aug; 10(8):1351-64. PubMed ID: 26136378
[TBL] [Abstract][Full Text] [Related]
43. Metal ion complexes of antivirally active nucleotide analogues. Conclusions regarding their biological action.
Sigel H
Chem Soc Rev; 2004 Mar; 33(3):191-200. PubMed ID: 15026824
[TBL] [Abstract][Full Text] [Related]
44. Amino Acid Ester Prodrugs of Nucleoside and Nucleotide Antivirals.
Krecmerova M
Mini Rev Med Chem; 2017; 17(10):818-833. PubMed ID: 28215138
[TBL] [Abstract][Full Text] [Related]
45. Metabolic pathways for activation of the antiviral agent 9-(2-phosphonylmethoxyethyl)adenine in human lymphoid cells.
Robbins BL; Greenhaw J; Connelly MC; Fridland A
Antimicrob Agents Chemother; 1995 Oct; 39(10):2304-8. PubMed ID: 8619586
[TBL] [Abstract][Full Text] [Related]
46. Cell-protecting effect against herpes simplex virus-1 and cellular metabolism of 9-(2-phosphonylmethoxyethyl)adenine in HeLa S3 cells.
Cerny J; Foster SA; Cheng YC
Mol Pharmacol; 1992 Sep; 42(3):537-44. PubMed ID: 1328849
[TBL] [Abstract][Full Text] [Related]
47. Phosphorylation of acyclic nucleotide analogs HPMPA and PMEA in L1210 mouse leukemia cell extracts.
Merta A; Veselý J; Votruba I; Rosenberg I; Holý A
Neoplasma; 1990; 37(2):111-20. PubMed ID: 2160620
[TBL] [Abstract][Full Text] [Related]
48. Synthesis and biological properties of prodrugs of (S)-3-(adenin-9-yl)-2-(phosphonomethoxy)propanoic acid.
Kaiser MM; Poštová-Slavětínská L; Dračínský M; Lee YJ; Tian Y; Janeba Z
Eur J Med Chem; 2016 Jan; 108():374-380. PubMed ID: 26706348
[TBL] [Abstract][Full Text] [Related]
49. Cytostatic activity of antiviral acyclic nucleoside phosphonates in rodent lymphocytes.
Zídek Z; Potmesil P; Holý A
Toxicol Appl Pharmacol; 2003 Nov; 192(3):246-53. PubMed ID: 14575642
[TBL] [Abstract][Full Text] [Related]
50. Pronounced in vitro and in vivo antiretroviral activity of 5-substituted 2,4-diamino-6-[2-(phosphonomethoxy)ethoxy] pyrimidines.
Balzarini J; Schols D; Van Laethem K; De Clercq E; Hocková D; Masojidkova M; Holý A
J Antimicrob Chemother; 2007 Jan; 59(1):80-6. PubMed ID: 17124193
[TBL] [Abstract][Full Text] [Related]
51. Evidence for distinction of the differentiation-inducing activities and cytostatic properties of 9-(2-phosphonylmethoxyethyl)adenine and a variety of differentiation-inducing agents in human erythroleukemia K562 cells.
Hatse S; De Clercq E; Balzarini J
Mol Pharmacol; 1996 Nov; 50(5):1231-42. PubMed ID: 8913355
[TBL] [Abstract][Full Text] [Related]
52. Erythrocyte-mediated delivery of a new homodinucleotide active against human immunodeficiency virus and herpes simplex virus.
Rossi L; Serafini S; Cappellacci L; Balestra E; Brandi G; Schiavano GF; Franchetti P; Grifantini M; Perno CF; Magnani M
J Antimicrob Chemother; 2001 Jun; 47(6):819-27. PubMed ID: 11389114
[TBL] [Abstract][Full Text] [Related]
53. (R)-9-(2-phosphonylmethoxypropyl)-2,6-diaminopurine is a potent inhibitor of feline immunodeficiency virus infection.
Vahlenkamp TW; De Ronde A; Balzarini J; Naesens L; De Clercq E; van Eijk MJ; Horzinek MC; Egberink HF
Antimicrob Agents Chemother; 1995 Mar; 39(3):746-9. PubMed ID: 7793884
[TBL] [Abstract][Full Text] [Related]
54. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
Andrei G; De Clercq E; Snoeck R
Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
[TBL] [Abstract][Full Text] [Related]
55. Activities of alkoxyalkyl esters of cidofovir (CDV), cyclic CDV, and (S)-9-(3-hydroxy-2-phosphonylmethoxypropyl)adenine against orthopoxviruses in cell monolayers and in organotypic cultures.
Lebeau I; Andrei G; Dal Pozzo F; Beadle JR; Hostetler KY; De Clercq E; van den Oord J; Snoeck R
Antimicrob Agents Chemother; 2006 Jul; 50(7):2525-9. PubMed ID: 16801436
[TBL] [Abstract][Full Text] [Related]
56. Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities.
Ying C; Holy A; Hocková D; Havlas Z; De Clercq E; Neyts J
Antimicrob Agents Chemother; 2005 Mar; 49(3):1177-80. PubMed ID: 15728921
[TBL] [Abstract][Full Text] [Related]
57. Mechanism of action of acyclic nucleoside phosphonates against herpes virus replication.
Neyts J; De Clercq E
Biochem Pharmacol; 1994 Jan; 47(1):39-41. PubMed ID: 8311844
[TBL] [Abstract][Full Text] [Related]
58. Acyclic nucleoside thiophosphonates as potent inhibitors of HIV and HBV replication.
Barral K; Weck C; Payrot N; Roux L; Durafour C; Zoulim F; Neyts J; Balzarini J; Canard B; Priet S; Alvarez K
Eur J Med Chem; 2011 Sep; 46(9):4281-8. PubMed ID: 21803462
[TBL] [Abstract][Full Text] [Related]
59. Synthesis and antiviral evaluation of 9-(S)-[3-alkoxy-2-(phosphonomethoxy)propyl]nucleoside alkoxyalkyl esters: inhibitors of hepatitis C virus and HIV-1 replication.
Valiaeva N; Wyles DL; Schooley RT; Hwu JB; Beadle JR; Prichard MN; Hostetler KY
Bioorg Med Chem; 2011 Aug; 19(15):4616-25. PubMed ID: 21719300
[TBL] [Abstract][Full Text] [Related]
60. Bis(tBuSATE) phosphotriester prodrugs of 8-azaguanosine and 6-methylpurine riboside; bis(pom) phosphotriester prodrugs of 2'-deoxy-4'-thioadenosine and its corresponding 9alpha anomer.
Rose JD; Parker WB; Secrist JA
Nucleosides Nucleotides Nucleic Acids; 2005; 24(5-7):809-13. PubMed ID: 16248041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]